“The results of this multi-center Phase III randomized trial provide evidence for intensity modulated proton therapy as a new standard-of-care treatment approach for the management of head and neck tumors,” says our @SJFrankMD of research presented at #ASCO24. (Abstract 6006) https://t.co/4MufV0nTCF @ASCO #EndCancer
Excitement was in the air at our 1st Procedural & Therapeutics Employee Awards!. Celebrating our amazing team's hard work is essential. Thanks to our academic partners for their support. @ACKoongMDPhD@sgswisher@MDAndersonNews
Health care systems that put protective measures in place early in an epidemic are more successful in containing an infection and meeting the capacity to serve. This is exactly @MDAndersonNews' intent as we take proactive steps to minimize the risk of #COVID2019 in our community.